Clinical Analysis of MOG Antibody‐Associated Disease Overlapped With Anti‐NMDA Receptor Encephalitis: A Long‐Term Retrospective Study
European Journal of Neuroscience · 2025-01 · 61 (1)
DOI: 10.1111/ejn.16654 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, online erschienen am 08.01.2025. Verfasst von Tianjiao Duan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Myelin-Oligodendrocyte Glycoprotein, Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Autoantibodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National natural science foundation of China, Natural Science Foundation of Hunan Province, Science and Technology Innovation Guidance Project of Hunan Province.
Abstract (Originalsprache)
To summarise the clinical characteristics, radiological features, treatments and prognosis of patients with myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) overlapped with NMDA receptor (NMDAR) encephalitis. We retrospectively analysed patients who exhibited dual positivity for MOG antibodies and NMDAR antibodies in serum/CSF from Jan 2018 to Jun 2023. Ten patients with MOGAD and NMDAR encephalitis were enrolled. The median age of initial attacks was 23 (range: 10–43) years old. Common symptoms were cortical encephalopathies (8/10), focal neurological deficits (4/10), as well as other presentations including headache, fever, optic neuritis and transverse myelitis. CSF pleocytosis was general (9/10, median 63.9 cells/μl). Lesions on brain MRI included brainstem (37.5%), cerebral cortex (33.3%), basal ganglia (25.0%) and hippocampus (20.8%). The average follow‐up duration was 25.4 months. 10/10 patients developed more than one relapse attacks, with MOG positivity before (10%), simultaneous (40%) or after anti‐NMDAR encephalitis (50%). Most patients (7/10) had good response to first‐line therapy but experienced next relapse with an average interval of 6.7 (range: 2–14) months. We conducted initial analysis of lymphocyte subsets in these patients, which revealed that CD3+ and CD4 + T cells increased after immunosuppressants medication ( p < 0.01 and p < 0.05, respectively). We concluded that MOGAD overlapping with NMDAR encephalitis presents a distinct clinical phenotype which differs from either MOGAD or NMDAR encephalitis. Brainstem in combination with cortical lesions might be warning signs for this overlapping syndrome. Due to the high recurrent rates, we recommend early diagnosis and timely treatment with efficient immunosuppressants at onset.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Clinical Medical Research Center for Stroke Prevention and Treatment of Hunan Province, Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Neurology, the Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
- The 'Double-First Class' Application Characteristic Discipline of Hunan Province (Clinical Medicine), Changsha Medical University, Changsha, Hunan, China.
- Department of Anesthesiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Tianjiao Duan
Förderung
- National natural science foundation of China
- Natural Science Foundation of Hunan Province
- Science and Technology Innovation Guidance Project of Hunan Province
- Changsha Municipal Natural Science Foundation
- Scientific Research Launch Project for New Employees of the Second Xiangya Hospital of Central South University
Zitieren
APA
Duan, T., Ouyang, S., Hu, Z., Zeng, Q., & Yin, W. (2025). Clinical Analysis of MOG Antibody‐Associated Disease Overlapped With Anti‐NMDA Receptor Encephalitis: A Long‐Term Retrospective Study. European Journal of Neuroscience, 61(1). https://doi.org/10.1111/ejn.16654
Vancouver
Duan T, Ouyang S, Hu Z, Zeng Q, Yin W. Clinical Analysis of MOG Antibody‐Associated Disease Overlapped With Anti‐NMDA Receptor Encephalitis: A Long‐Term Retrospective Study. European Journal of Neuroscience. 2025;61(1). doi:10.1111/ejn.16654
BibTeX
@article{Duan2025,
author = {Duan, Tianjiao and Ouyang, Song and Hu, Zhaolan and Zeng, Qiuming and Yin, Weifan},
title = {Clinical Analysis of MOG Antibody‐Associated Disease Overlapped With Anti‐NMDA Receptor Encephalitis: A Long‐Term Retrospective Study},
journal = {European Journal of Neuroscience},
year = {2025},
volume = {61},
number = {1},
doi = {10.1111/ejn.16654}
}
EUVIMED